Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-L-iduronidase mutations causing mucopolysaccharidosis type I

被引:2
|
作者
Kasper, David C. [1 ,2 ]
Iqbal, Furhan [1 ]
Dvorakova, Lenka [3 ,4 ,5 ]
Zeman, Jiri [3 ,4 ,5 ]
Magner, Martin [3 ,4 ,5 ]
Bodamer, Olaf [6 ]
Pollak, Arnold [1 ]
Herkner, Kurt R. [1 ,2 ]
Item, Chike B. [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Pediat & Adolescent Med, Lab Inherited Metab Disorders, A-1090 Vienna, Austria
[2] Med Univ Vienna, Res Core Unit Pediat Biochem & Analyt, A-1090 Vienna, Austria
[3] Charles Univ Prague, Inst Inherited Metab Disorders, Prague, Czech Republic
[4] Charles Univ Prague, Dept Pediat, Fac Med 1, Prague, Czech Republic
[5] Charles Univ Prague, Gen Teaching Hosp, Prague, Czech Republic
[6] Paracelsus Med Univ, Univ Childrens Hosp, Salzburg, Austria
关键词
Mucopolysaccharidosis type I; MPS I; alpha-L-Iduronidase; IDUA; dHPLC; IDENTIFICATION; DISEASE; FREQUENCY;
D O I
10.1016/j.cca.2009.11.027
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Mutations in the alpha-L-iduronidase A (IDUA) gene cause mucopolysacchariclosis type I (MPS I). a progressive multisystem disorder with features ranging over a continuum from mild to severe which is inherited in an autosomal recessive manner. To date over 100 mutations are known, nonetheless genotype-phenotype prediction is complicated and hampered due to attenuating polymorphisms. rare sequence variants, varied genetic backgrounds and environmental effects. Methods: In this study we report the first development of a denaturating high performance liquid chromatography (dHPLC) protocol for the rapid and accurate detection of recently described mutations in the IDUA gene. Optimal PCR running and dHPLC partial denaturing conditions for mutation detection were established for each PCR amplicon corresponding to 14 IDUA exons and their adjacent intronic/flanking sequences. Results: A total of 12 different mutations, 5 nonsense. 4 missense, 1 deletion, and 2 splice site (intron). in 10 MPS I patients were screened. All mutations revealed a distinct dHPLC pattern thus enabling their accurate detection. Conclusions: A dHPLC screening method was developed for the detection of mutations and sequence variants in the IDUA gene and the results presented in this study revealed that this promising method proved to be robust. automated. economical and above all, highly sensitive. Costs for the detection of mutations causing MPS I disease should be reduced by using this method as a pre-analytical tool followed by sequencing of aberrant heteroduplexforming amplicons. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 50 条
  • [1] Denaturating High Performance Liquid Chromatography Protocol for the Detection of α-L-Iduronidase Mutations causing Mucopolysaccharidosis Type I
    Item, C. B.
    Herkner, K. R.
    Kasper, D. C.
    EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (03) : 385 - 385
  • [2] Mucopolysaccharidosis type I:: Characterization of novel mutations affecting α-L-iduronidase activity
    Lee-Chen, GJ
    Lin, SP
    Tang, YF
    Chin, YW
    CLINICAL GENETICS, 1999, 56 (01) : 66 - 70
  • [3] Mucopolysaccharidosis type I:: Identification and characterization of mutations affecting α-L-iduronidase activity
    Lee-Chen, GJ
    Lin, SP
    Chen, IS
    Chang, JH
    Yang, CW
    Chin, YW
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (06) : 425 - 428
  • [4] Mucopolysaccharidosis I:: α-L-Iduronidase mutations in three Tunisian families
    Laradi, S
    Tukel, T
    Erazo, M
    Shabbeer, J
    Chkioua, L
    Khedhiri, S
    Ferchichi, S
    Chaabouni, M
    Miled, A
    Desnick, RJ
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (06) : 1019 - 1026
  • [5] Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma α-L-iduronidase
    Mandelli, J
    Wajner, A
    Pires, R
    Giugliani, R
    Coelho, JC
    CLINICA CHIMICA ACTA, 2001, 312 (1-2) : 81 - 86
  • [6] Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte α-l-iduronidase
    Mandelli, J
    Wajner, A
    Pires, RF
    Giugliani, R
    Coelho, JC
    ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (01) : 20 - 24
  • [7] Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
    Sun, Luning
    Li, Chunyi
    Song, Xiaoyu
    Zheng, Ningning
    Zhang, Haipeng
    Dong, Guizhang
    GENETICS AND MOLECULAR BIOLOGY, 2011, 34 (02) : 195 - 200
  • [8] Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
    Li, Ying
    Liu, Deyun
    Yu, Yue
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [9] Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment
    Valeska Lizzi Lagranha
    Barbara Zambiasi Martinelli
    Guilherme Baldo
    Giuseppe Ávila Testa
    Talita Giacomet de Carvalho
    Roberto Giugliani
    Ursula Matte
    Journal of Materials Science: Materials in Medicine, 2017, 28
  • [10] Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients
    Oussoren, Esmee
    Keulemans, Joke
    van Diggelen, Otto P.
    Oemardien, Linda V.
    Timmermans, Remco G.
    van der Ploeg, Ans T.
    Ruijter, George J. G.
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (04) : 377 - 381